Shanghai Yizhong Pharmaceutical Co., Ltd. (SHA:688091)

SHA:688091 Revenue

Shanghai Yizhong Pharmaceutical had revenue of 86.68M CNY in the quarter ending June 30, 2026, a decrease of -2.91%. This brings the company's total for the last twelve months to 321.61M, up 51.76% year-over-year. In the year 2025, Shanghai Yizhong Pharmaceutical had annual revenue of 316.08M with 82.14% growth. That makes Shanghai Yizhong Pharmaceutical the 28,227th largest company in the world by revenue and 4,832nd in China.

• Revenue (ttm): 321.61M
• Revenue Growth: +51.76%
• P/S Ratio: 23.97
• Revenue / Employee: 703.73K
• Employees: 457
• Market Cap: 7.71B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	316.08M	142.54M	82.14%
Dec 31, 2024	173.53M	-186.72M	-51.83%
Dec 31, 2023	360.25M	124.30M	52.68%
Dec 31, 2022	235.96M	231.88M	5,686.75%
Dec 31, 2021	4.08M	-	-

Data Source: S&P Global Market Intelligence Last updated: Aug 25, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 22, 2026

Data Sources Report a data error